Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic PropertiesMatthew D. Hill, Andrew P. Degnan, John S. Tokarski et al.|ACS Medicinal Chemistry Letters|2022Cited by 10
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A. Markwalder, Steven P. Seitz, Aaron Balog et al.|Bioorganic & Medicinal Chemistry Letters|2023Cited by 7
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotypeMatthew D. Hill, Andrew P. Degnan, Claude Quesnelle et al.|Bioorganic & Medicinal Chemistry Letters|2021Cited by 6
Synthesis and Biological Evaluation of Biaryl Alkyl Ethers as Inhibitors of IDO1Jay A. Markwalder, Steven P. Seitz, Aaron Balog et al.|SSRN Electronic Journal|2023Cited by 1